Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Respiratory Disease Testing Market Size Rare Kidney Diseases Treatment Market Size Commercial Vehicle Tire Cords Market Size Motorcycle Handle Grip Market SizeGlobal Shrimp Disease Diagnostics Market Size to Exceed USD 12.95 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Shrimp Disease Diagnostics Market Size is Expected to Grow from USD 5.65 Billion in 2023 to USD 12.95 Billion by 2033, at a CAGR of 8.65% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Shrimp Disease Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Disease (Bacterial Diseases, Viral Diseases, Parasitic Diseases, Fungal Diseases, and Other Diseases), By End-User (Shrimp Farmers, Veterinarians, Researchers, and Diagnostic Labora), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The shrimp disease diagnostics market is a worldwide business that deals with the detection, identification, and surveillance of shrimp farming diseases. The market incorporates diagnostic equipment, kits, reagents, and technologies such as PCR, immunoassays, and microscopy used to identify viral, bacterial, and fungal disease infections. This market is fuelled by expansion in shrimp farming, growing occurrences of diseases, and advances in aquaculture diagnostics. Furthermore, the major driving forces of the global market for shrimp disease diagnosis are growth in shrimp farming, growing cases of disease outbreaks, and the necessity for early detection and accurate disease diagnosis. Technology advancements in diagnosis, investments in aquaculture, and biosecurity regulations favoring government actions also propel the market forward. Increased awareness of shrimp farmers and the demand for sustainable seafood production also drive market growth. However, the high diagnostic costs, lack of standardized testing methods, limited awareness among farmers, inadequate infrastructure in developing regions, and challenges in early disease detection are key restraining factors in the global shrimp disease diagnosis market.
The bacterial diseases segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the disease, the global shrimp disease diagnostics market is divided into bacterial diseases, viral diseases, parasitic diseases, fungal diseases, and other diseases. Among these, the bacterial diseases segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to the high prevalence of infections such as vibriosis and necrosis in shrimp farming. Increased disease outbreaks, rising demand for early diagnosis, and advancements in bacterial detection technologies drive its significant CAGR. Additionally, growing aquaculture practices and stringent disease control regulations further support market expansion.
The shrimp farmers segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.
On the basis of the end-use, the global shrimp disease diagnostics market is divided into shrimp farmers, veterinarians, researchers, and diagnostic labora. Among these, the shrimp farmers segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is attributed to the rising adoption of disease diagnostic solutions to prevent losses and ensure high-yield production. Increasing disease outbreaks, growing awareness, and government support for sustainable aquaculture practices drive its substantial CAGR. Additionally, advancements in affordable and rapid diagnostic methods further boost market growth.
North America is projected to hold the largest share of the global shrimp disease diagnostics market over the forecast period.
North America is projected to hold the largest share of the global shrimp disease diagnostics market over the forecast period. The regional growth is propagated to advanced aquaculture practices, high adoption of diagnostic technologies, and strong regulatory frameworks ensuring shrimp health. Increasing investments in sustainable shrimp farming, rising seafood consumption, and growing awareness among farmers about disease prevention further drive market growth in the region.
Asia Pacific is expected to grow at the fastest CAGR growth of the global shrimp disease diagnostics market during the forecast period. The regional growth is attributed to its dominance in global shrimp farming, increasing disease outbreaks, and rising adoption of advanced diagnostic techniques. Government initiatives supporting sustainable aquaculture, growing awareness among shrimp farmers, and expanding seafood exports further drive market growth. Additionally, technological advancements in rapid disease detection enhance regional expansion.
Company Profiling
Major vendors in the global shrimp disease diagnostics market are Merck KGaA, Promega Corporation, Thermo Fisher Scientific, BioTechne, QIAGEN, Zoetis, Abcam plc, Mérieux NutriSciences, BioRad Laboratories, PerkinElmer, Neogen Corporation, BioMérieux, Fujifilm Wako Diagnostics, IDEXX Laboratories, GenScript Biotech Corporation, and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global shrimp disease diagnostics market based on the below-mentioned segments:
Global Shrimp Disease Diagnostics Market, By Disease
Global Shrimp Disease Diagnostics Market, By End-Use
Global Shrimp Disease Diagnostics Market, By Regional
May 2025 - Global Graft Versus Host Disease (GVHD) Treatment Market Size is Expected to Grow from USD 2.53 Billion in 2023 to USD 5.45 Billion by 2033, at a CAGR of 7.98% during the forecast period 2023-2033.
May 2025 - The Global Small Animals Respiratory Diseases Treatment Market Size is Expected to Grow from USD 25.18 Million in 2023 to USD 33.94 Million by 2033, at a CAGR of 3.03% during the forecast period 2023-2033.
May 2025 - The Global Rail Vehicle Sanitation System Market Size is Expected to Grow from USD 1.23 Billion in 2023 to USD 2.52 Billion by 2033, Growing at a CAGR of 7.44% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
